References
- EA Lock, and MF Wilks. ParaquatHandbook of pesticide toxicology 2ndRI Krieger. Academic Press, San Diego, CA, (2001), 1559–1592.
- M Eddleston, MF Wilks, and NA Buckley. (2003). Prospects for treatment of paraquat-induced lung fibrosis with immunosuppressive drugs and the need for better prediction of outcome: a systematic review. Q J Med 96:809–824.
- C Bismuth, R Garnier, S Dally, PE Fournier, and JM Schermann. (1982). Prognosis and treatment of paraquat poisoning: a review of 28 cases. J Toxicol Clin Toxicol 19:461–474.
- JA Vale, TH Meredith, and BM Buckley. (1987). Paraquat poisoning: clinical features and immediate general management. Hum Toxicol 6:41–47.
- JL Lin, DT Lin-Tan, KH Chen, and WH Huang. (2006). Repeated pulse of methylprednisolone and cyclophosphamide with continuous dexamethasone therapy for patients with severe paraquat poisoning. Crit Care Med 34 (2):368–373.
- TJ Gross, and GW Hunninghake. (2001). Idiopathic pulmonary fibrosis. N Engl J Med 345:517–525.
- RV Nair, X Huang, R Shorthouse, and et al. (1997). Antiproliferative effect of rapamycin on growth factor-stimulated human adult lung fibroblasts in vitro may explain its superior efficacy for prevention and treatment of allograft obliterative airway disease in vitro. Transplant Proc 29:614–615.
- L Buschhausen, M Kamm, W Arns, and et al. (Mar 15, 2005). Successful treatment of a severe case of idiopathic pulmonary fibrosis with rapamycin. Med Klin 100 (3):161–4. (Munich)
- SN Sehgal. (1998). Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 31:335–340.